-
Firefly Luciferase mRNA as a Delivery Integrity Readout
2026-09-26
Firefly Luciferase mRNA (ARCA, 5-moUTP) can do more than report expression: it can help distinguish whether a delivery system preserves functional RNA from whether cells simply take up particles. This article connects reporter-assay design with research on pH-responsive protection of RNA lipid nanoparticles, while clarifying what luminescence can—and cannot—show.
-
Halazone: From Water Disinfection to Nerve Biology
2026-09-25
Halazone links HOCl-mediated water disinfection with a distinct electrophysiology observation: disrupted sodium-current inactivation in frog nerve fibers. Learn how to interpret the evidence, design bounded assays, and avoid overextending cross-domain claims.
-
DCPS Links m7G Biology to Diabetic Foot Ulcers
2026-09-25
A 2025 study identified decapping scavenger enzyme (DCPS) as a candidate biomarker associated with diabetic foot ulcers (DFUs), combining gene-expression analyses with patient and mouse tissue validation. In keratinocytes, DCPS knockdown was associated with impaired cell-cycle progression, proliferation, and migration and with increased apoptosis, supporting further study of DCPS in epithelial wound repair while leaving its causal molecular pathway to be clarified.
-
DAT PET Tracks Dopamine Neuron Graft Maturation
2026-09-24
Goggi and colleagues used serial PET imaging to assess human embryonic stem cell-derived dopaminergic grafts in a rat model of Parkinson’s disease. Their results suggest that dopamine transporter imaging can track graft maturation and differentiation in vivo, while a second PET measure, behavioral testing, and histology provide complementary evidence of function and outcome.
-
Calcitriol Workflows for Bone Homeostasis Research
2026-09-24
Use Calcitriol as a controlled vitamin D receptor perturbation in bone-cell experiments—without assuming it reproduces NFIA’s effects on bone remodeling. This workflow pairs practical dosing and handling guidance with assay designs that distinguish VDR responses from the RANKL–SFRP1 mechanisms identified in a recent NFIA study.
-
Budesonide Workflows for Airway Inflammation Research
2026-09-24
Pair Budesonide’s anti-inflammatory activity with biomimetic permeability assays to separate membrane-partitioning behavior from functional effects in airway models. A practical workflow shows when to choose IAM LC or LEKC, how to handle the compound, and how to troubleshoot common assay failures.
-
AZ505 SMYD2 Inhibitor: Applied Research Workflow
2026-09-23
Learn how to use AZ505 to connect biochemical SMYD2 inhibition with cellular methylation, inflammatory, and fibrosis readouts. The workflow combines substrate-competitive assay design, disease-relevant validation, and practical troubleshooting for epigenetic regulation research and cancer biology research.
-
Making RNA Readouts Translationally Actionable
2026-09-22
A mechanistic framework for using Cy5-labeled RNA probes to connect TREM2 engineering, macrophage efferocytosis, and tissue-level translational evidence.
-
Optimized hiPSC Platelet Production: Study Insights
2026-09-22
Yue and colleagues developed an optimized differentiation scheme that combines higher embryoid-body input, human platelet lysate, small-molecule cytokine substitutes, and maturation-promoting compounds to improve platelet generation from human induced pluripotent stem cells. The resulting platform shortened production to 19 days, increased reported output, supported functional clot formation, and reduced estimated costs, while still requiring further validation for scale-up and clinical translation.
-
Ertapenem Sodium Salt: A Translational Resistance Lens
2026-09-21
Ertapenem is more than a broad-spectrum antibacterial reagent: it is a practical bridge between penicillin-binding protein biology, susceptibility testing, carbapenemase surveillance, and translational pharmacology. This article shows how Ertapenem sodium salt can help researchers connect phenotype, genotype, plasmid mobility, and experimental design in antibiotic resistance research.
-
Novel PDK4 Inhibitors: Study Findings and Methods
2026-09-21
The 2019 Journal of Medicinal Chemistry study developed an allosteric inhibitor series from an anthraquinone hit and identified compound 8c as a potent PDK4 inhibitor with activity in metabolic, allergic, and cancer-related models. Its integrated medicinal chemistry, pharmacokinetic, animal, and docking data provide a useful framework for evaluating PDK4-directed small molecules while highlighting the limits of preclinical translation.
-
CLK2, BRCA1, and Platinum Resistance in Ovarian Cancer
2026-09-20
The reference study identifies CLK2 as a mediator of platinum resistance in ovarian cancer and links its activity to phosphorylation of BRCA1 at Ser1423 and enhanced DNA damage repair. Its combination of tissue profiling, cellular assays, mechanistic analysis, and xenograft validation provides a framework for evaluating CLK2 as a treatment-resistance target, while also defining important limits for translating broad Cdc2-like kinase pharmacology into a CLK2-specific conclusion.
-
BipD Hijacks Mitophagy in B. pseudomallei Infection
2026-09-19
The reference study identifies the Burkholderia pseudomallei type III secretion system protein BipD as an effector that redirects host mitophagy to support intracellular bacterial survival. Its mechanistic contribution is the definition of a BipD–KLHL9/KLHL13–CUL3 ubiquitination axis targeting IMMT at K211, linking mitochondrial ubiquitination, reduced mitochondrial ROS, and evasion of macrophage killing.
-
EdU Flow Cytometry Assay Kits (Cy5) for S-Phase
2026-09-19
EdU Flow Cytometry Assay Kits (Cy5) enable denaturation-free measurement of DNA synthesis, making them useful for multiplexed cell-cycle, immunophenotyping, and pharmacodynamic workflows. This guide connects click chemistry DNA synthesis detection with colorectal cancer research and provides practical setup, optimization, and troubleshooting strategies.
-
ROS-Responsive Lipid Nanoparticles for RAS-Targeted mRNA
2026-09-18
Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids to preferentially deliver mRNA into tumor cells. Their lead formulation, BAmP-TK-12, enabled delivery of DUF5 mRNA to deplete mutant RAS and produced stronger antitumor effects than a small-molecule RAS inhibitor in the reported models.